KDSTEM / EHL Bio - LARVOL DELTA

Safety and Efficacy of KDSTEM Inj. in Patients With Chronic Kidney Disease (clinicaltrials.gov) - P1 | N=6 | Completed | Sponsor: EHL Bio Co., Ltd. | Trial completion date: Sep 2025 ➔ Mar 2026 | Trial primary completion date: Apr 2025 ➔ Mar 2026 | Recruiting ➔ Completed

Trial completion • Trial completion date • Trial primary completion date • Chronic Kidney Disease • Nephrology • Renal Disease • CXCL8

Safety and Efficacy of KDSTEM Inj. in Patients With Chronic Kidney Disease (clinicaltrials.gov) - P1 | N=6 | Recruiting | Sponsor: EHL Bio Co., Ltd. | Not yet recruiting ➔ Recruiting | Initiation date: Nov 2023 ➔ Feb 2024

Enrollment open • Trial initiation date • Chronic Kidney Disease • Nephrology • Renal Disease